A successful colonoscopy starts with a complete colonoscopy prep

Colonoscopy is the best available test for detecting and preventing colon cancer, but a successful colonoscopy requires a complete colonoscopy prep. Chances are you've heard that preparing for a colonoscopy is no picnic. It's true. The colonoscopy prep process may not be the most glamorous activity, but it is crucial to this potentially lifesaving procedure. That's because an effective colonoscopy prep allows your doctor to examine the entire lining of your colon for abnormal growths, which may grow into cancer if they are not detected and removed.

MoviPrep is a low-volume colonoscopy prep that is proven to provide a clear view of the entire colon, allowing your doctor to detect abnormal growths.1 That's one reason why MoviPrep is the #1-prescribed branded colonoscopy prep in the United States.2

Your helpful guide for the colonoscopy prep process

Rest assured, getting a colonoscopy is time well spent toward living a healthier lifestyle. To help make the process more tolerable, we created this Web site to help guide you through the weeks and days leading up to your colonoscopy. Within the site, you will find helpful tools, such as the My MoviMent Prep Kit and a sample calendar for the time leading up to your colonoscopy . You can also read about others' experiences and learn more about the colonoscopy prep, colonoscopy, and colon cancer.

Important Safety Information about MOVIPREP

MOVIPREP® (PEG-3350, sodium sulfate, sodium chloride, potassium chloride, sodium ascorbate and ascorbic acid for oral solution) is an osmotic laxative indicated for cleansing of the colon as a preparation for colonoscopy in adults 18 years of age or older. MOVIPREP is contraindicated in patients with gastrointestinal (GI) obstruction, bowel perforation, gastric retention, ileus, toxic colitis or toxic megacolon, and patients who have had a severe hypersensitivity reaction to any of its components. MOVIPREP should be used with caution in patients at risk of or with fluid and electrolyte abnormalities, hyponatremia, arrhythmias, seizures, in patients with impaired renal function or patients taking concomitant medications that affect renal function, patients with known or suspected inflammatory bowel disease, patients with suspected GI obstruction or perforation, patients at risk for aspiration, and patients with glucose-6-phosphate dehydrogenase deficiency. Most common adverse reactions for split dosing (incidence ≥5%) are malaise, nausea, abdominal pain, vomiting, and upper abdominal pain. The most common adverse reactions for evening only dosing (incidence ≥5%) are abdominal distension, anal discomfort, thirst, nausea, abdominal pain, sleep disorder, rigors, hunger, malaise, vomiting, and dizziness. MOVIPREP contains 233 mg of phenylalanine per treatment. Advise patients to hydrate adequately before, during, and after the use of MOVIPREP.

You are encouraged to report negative side effects to the FDA. Visit www.fda.gov/safety/medwatch/ or call 1-800-FDA-1088.

Complete Prescribing Information pdf icon

For Dummies is a registered trademark of Wiley Publishing, Inc.

References: 1. MoviPrep [prescribing information]. Morrisville, NC: Salix Pharmaceuticals, Inc; 2011. 2. Medi-Span® Price Rx® [database online]. Indianapolis, IN: Wolters Kluwer Health. http://www.medispan.com/drug-pricing-analysis-pricerx.aspx. Accessed July 18, 2011.